Pharma Journalist - Page 84 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA Accepts Gilead’s NDA for Twice-Yearly Lenacapavir for HIV Prevention

Biogen and Stoke Therapeutics Partner to Develop Zorevunersen for Dravet Syndrome Treatment

FDA Grants Breakthrough Therapy Designation to Innate Pharma’s Lacutamab for Sézary Syndrome

FDA Grants Full Approval of Deciphera’s ROMVIMZA for TGCT Treatment

FDA Approves GSK’s Penmenvy 5-in-1 Meningococcal Vaccine for MenABCWY Protection

QIAGEN Expands Bioinformatics Leadership with New Data Center in Australia/APAC

Newleos Therapeutics Raises $93.5M in Oversubscribed Series A to Advance Neuropsychiatric Disorder Treatments

Nemluvio Approved in EU for Atopic Dermatitis and Prurigo Nodularis

MaxCyte Signs Platform License with TG Therapeutics for Autoimmune Cell Therapies

Health Canada Approves Merck’s KEYTRUDA for Resectable NSCLC with Chemotherapy